{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:35:47Z","timestamp":1783118147792,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbadis.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T03:47:53Z","timestamp":1491536873000},"page":"1292-1299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts"],"prefix":"10.1016","volume":"1863","author":[{"given":"Bruno","family":"Lefort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Gouache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Acquaviva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Tardieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Fran\u00e7ois","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phan","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Vianey-Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Labarthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.04.005_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bst0280177","article-title":"The mitochondrial trifunctional protein: centre of a beta-oxydation metabolon?","volume":"28","author":"Eaton","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymgme.2005.02.002","article-title":"Neonatal screening for defects of the mitochondrial trifunctional protein","volume":"85","author":"Sander","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2005.062000","article-title":"Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene","volume":"52","author":"Das","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10545-005-0533-8","article-title":"Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency","volume":"28","author":"Olpin","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2011.04.006","article-title":"Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency","volume":"103","author":"Boutron","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10545-010-9244-x","article-title":"Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening","volume":"34","author":"Sykut-Cegielska","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1023\/A:1005340322558","article-title":"Neonatal lethal mitochondrial trifunctional protein deficiency mimicking a respiratory chain defect","volume":"20","author":"Gr\u00fcnewald","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defect: a series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.10211","article-title":"Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations","volume":"21","author":"Spiekerkoetter","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10545-013-9611-5","article-title":"Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability","volume":"36","author":"Olpin","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01963564","article-title":"3-hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment","volume":"150","author":"Duran","year":"1991","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1023\/A:1005504223140","article-title":"Disorders of mitochondrial fatty acyl-CoA beta-oxidation","volume":"22","author":"Wanders","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10545-012-9542-6","article-title":"Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients","volume":"36","author":"Baruteau","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10545-009-9001-1","article-title":"Fatty acid oxidation disorders: outcome and long-term prognosis","volume":"33","author":"Wilcken","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1067\/mpd.2003.231","article-title":"Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement","volume":"142","author":"den Boer","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10545-009-1125-9","article-title":"Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10557-008-6084-0","article-title":"Medium-chain fatty acids as metabolic therapy in cardiac disease","volume":"22","author":"Labarthe","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ymgme.2015.10.005","article-title":"Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: review of 15years experience","volume":"116","author":"Roe","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004310050063","article-title":"Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls","volume":"159","author":"Das","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0925-4439(95)00064-B","article-title":"Inhibition of oxidative phosphorylation by palmitoyl-CoA in digitonin permeabilized fibroblasts: implications for long-chain fatty acid beta-oxidation disorders","volume":"1272","author":"Ventura","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10863-012-9481-9","article-title":"Long-chain 3-hydroxy fatty acids accumulated in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria","volume":"45","author":"Tonin","year":"2013","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbabio.2015.04.003","article-title":"Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency","volume":"1847","author":"Hickmann","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0120","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1111\/febs.13526","article-title":"Deregulation of mitochondrial functions provoked by LCHFA accumulating in LCHAD and MTP deficiencies in rat heart: mPT pore opening as a potential contributing pathomechanism of cardiac alterations in these disorders","volume":"282","author":"Cecatto","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbabio.2016.01.002","article-title":"Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells","volume":"1857","author":"Peyta","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0135","first-page":"10","article-title":"Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD)","volume":"22","author":"Karall","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ymgme.2005.07.030","article-title":"Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects","volume":"86","author":"Ventura","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2006.11.109","article-title":"Inhibition of adenine nucleotide transport in rat liver mitochondria by long-chain acyl-coenzyme A beta-oxidation intermediates","volume":"352","author":"Ventura","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.lfs.2010.04.003","article-title":"Disturbance of mitochondrial energy homeostasis caused by the metabolites accumulating in LCHAD and MTP deficiencies in rat brain","volume":"86","author":"Tonin","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0155","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bbadis.2014.06.011","article-title":"Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?","volume":"1842","author":"Tonin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1152\/ajpheart.01307.2007","article-title":"Different effects of palmitoyl-l-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes","volume":"295","author":"Tominaga","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbabio.2013.10.004","article-title":"Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation","volume":"1837","author":"Chaban","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10545-016-9915-3","article-title":"Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation","volume":"39","author":"McCoin","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0960-8966(96)00352-5","article-title":"Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G1528C mutation","volume":"6","author":"Tyni","year":"1996","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3476(00)70111-9","article-title":"Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzymeA dehydrogenase deficiency","volume":"136","author":"Enns","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/mgme.2000.3009","article-title":"A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene","volume":"70","author":"Vladutiu","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0190","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10545-010-9115-5","article-title":"The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population","volume":"33","author":"Schatz","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment-A retrospective chart review","volume":"116","author":"Vockley","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2016.08.008","article-title":"Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders","volume":"119","author":"Vockley","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0205","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1203\/01.PDR.0000059748.67987.1F","volume":"53","author":"Jones","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0210","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1515\/bchm3.1988.369.2.1267","article-title":"Utilization of medium-chain triglycerides and octanoic acid by cultured human fibroblasts and lymphoblasts","volume":"369","author":"Lemmen","year":"1988","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0215","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator Perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozquia","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-2007-980016","article-title":"Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir\u00ae","volume":"27","author":"Schmitz","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs0990027","article-title":"First clinical trial with etomoxir in patients with chronic congestive heart failure","volume":"99","author":"Schmidt-Schweda","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20060307","article-title":"A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison","volume":"113","author":"Holubarsch","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbadis.2017.04.005_bb0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FTD.0000000000000237","article-title":"Can Perhexiline be utilized without long-term toxicity? A clinical practice audit","volume":"38","author":"Phuong","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.bbadis.2017.04.005_bb0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917301175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917301175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T22:29:17Z","timestamp":1535927357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917301175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0925443917301175"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.04.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}